Generic Drug Product approval is most stringent and crucial process for company with different rules and regulation in different country. For the registration of the product company has to follow regulatory rules and requirement of country specific agency. Company should apply product marketing authorization as per norms of country requirements and should manage life cycle of that product throughout market. Need to understand and describe the various regulatory requirements for the generic drug approval process and comparison of regulated country. To understand the technical requirements required to market medicines in regulated pharmaceutical market. To evaluate similarities and differences within regulated market of U.S, Canada, and Europ...
A generic medicine is a faithful copy of a mature drug - no longer under patent - marketed with the ...
AbstractThe present study was aimed to study the requirements of bioequivalence for the registration...
Generic drugs have a key role to play in the efficient allocation of financial resources for pharmac...
Generic Drug Product approval is most stringent and crucial process for company with different rules...
Common Technical Document (CTD) provides a standardized structure for regulatory submissions that is...
Common Technical Document (CTD) provides a standardized structure for regulatory submissions that is...
United States (US) and the EU are the largest and the most potential markets for in the world and ar...
ABSTRACT Common technical document (CTD) provides a standardized structure for regulatory submissio...
Different regulatory authorities regulate the drug development in various countries of the world. Va...
The goal of this study is to understand differences in regulatory requirements, bio-equivalence data...
The purpose of the study was to compare generic drug registration process and to find out the differ...
Different regulatory authorities regulate the drug development in various countries of the world. Va...
Our aim was to systematically identify and compare how generic medications, as defined by the US Foo...
Our aim was to systematically identify and compare how generic medications, as defined by the US Foo...
A regulatory process, by which a person/organization/sponsor/innovator gets authorization to launch ...
A generic medicine is a faithful copy of a mature drug - no longer under patent - marketed with the ...
AbstractThe present study was aimed to study the requirements of bioequivalence for the registration...
Generic drugs have a key role to play in the efficient allocation of financial resources for pharmac...
Generic Drug Product approval is most stringent and crucial process for company with different rules...
Common Technical Document (CTD) provides a standardized structure for regulatory submissions that is...
Common Technical Document (CTD) provides a standardized structure for regulatory submissions that is...
United States (US) and the EU are the largest and the most potential markets for in the world and ar...
ABSTRACT Common technical document (CTD) provides a standardized structure for regulatory submissio...
Different regulatory authorities regulate the drug development in various countries of the world. Va...
The goal of this study is to understand differences in regulatory requirements, bio-equivalence data...
The purpose of the study was to compare generic drug registration process and to find out the differ...
Different regulatory authorities regulate the drug development in various countries of the world. Va...
Our aim was to systematically identify and compare how generic medications, as defined by the US Foo...
Our aim was to systematically identify and compare how generic medications, as defined by the US Foo...
A regulatory process, by which a person/organization/sponsor/innovator gets authorization to launch ...
A generic medicine is a faithful copy of a mature drug - no longer under patent - marketed with the ...
AbstractThe present study was aimed to study the requirements of bioequivalence for the registration...
Generic drugs have a key role to play in the efficient allocation of financial resources for pharmac...